1.29
price up icon5.74%   0.07
after-market Dopo l'orario di chiusura: 1.31 0.02 +1.55%
loading
Precedente Chiudi:
$1.22
Aprire:
$1.24
Volume 24 ore:
520.92K
Relative Volume:
0.31
Capitalizzazione di mercato:
$88.35M
Reddito:
$129.87M
Utile/perdita netta:
$-44.09M
Rapporto P/E:
-1.5636
EPS:
-0.825
Flusso di cassa netto:
$-30.55M
1 W Prestazione:
-3.01%
1M Prestazione:
-28.33%
6M Prestazione:
-62.72%
1 anno Prestazione:
-71.59%
Intervallo 1D:
Value
$1.23
$1.315
Intervallo di 1 settimana:
Value
$1.201
$1.455
Portata 52W:
Value
$1.17
$5.34

Neuronetics Inc Stock (STIM) Company Profile

Name
Nome
Neuronetics Inc
Name
Telefono
877-600-7555
Name
Indirizzo
3222 PHOENIXVILLE PIKE, MALVERN, PA
Name
Dipendente
716
Name
Cinguettio
@tmstherapy
Name
Prossima data di guadagno
2026-03-17
Name
Ultimi documenti SEC
Name
STIM's Discussions on Twitter

Compare STIM vs ABT, SYK, MDT, BSX, EW

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Devices icon
STIM
Neuronetics Inc
1.29 83.55M 129.87M -44.09M -30.55M -0.825
Medical Devices icon
ABT
Abbott Laboratories
110.25 192.10B 44.33B 6.50B 7.40B 3.717
Medical Devices icon
SYK
Stryker Corp
345.78 137.25B 25.12B 3.25B 4.28B 8.3984
Medical Devices icon
MDT
Medtronic Plc
88.97 115.41B 35.48B 4.64B 5.41B 3.582
Medical Devices icon
BSX
Boston Scientific Corp
69.63 103.81B 20.08B 2.89B 3.66B 1.9391
Medical Devices icon
EW
Edwards Lifesciences Corp
85.09 49.82B 6.07B 1.06B 1.34B 1.8063

Neuronetics Inc Stock (STIM) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-08-13 Downgrade William Blair Outperform → Mkt Perform
2021-10-13 Downgrade BTIG Research Buy → Neutral
2021-10-13 Downgrade William Blair Outperform → Mkt Perform
2021-01-22 Aggiornamento William Blair Mkt Perform → Outperform
2020-02-06 Iniziato BTIG Research Buy
2018-07-24 Iniziato Canaccord Genuity Buy
Mostra tutto

Neuronetics Inc Borsa (STIM) Ultime notizie

pulisher
02:16 AM

Neuronetics, Inc. Hits New 52-Week Low at $1.19 Amid Declining Stock Performance - Markets Mojo

02:16 AM
pulisher
Mar 10, 2026

Neuronetics to Report Fourth Quarter 2025 Results March 17 - MyChesCo

Mar 10, 2026
pulisher
Mar 07, 2026

Can Neuronetics Inc. stock sustain free cash flow growth2025 Geopolitical Influence & Verified Technical Trade Signals - Naître et grandir

Mar 07, 2026
pulisher
Mar 06, 2026

Aug Momentum: Can Neuronetics Inc outperform in the next rallyBuy Signal & Weekly High Potential Stock Alerts - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 06, 2026

Volatility Watch: Why is Neuronetics Inc stock going upMarket Trend Review & Fast Gaining Stock Strategy Reports - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 04, 2026

STIM (NASDAQ: STIM) insider notifies sales; Macan sold 20,?32 shares - Stock Titan

Mar 04, 2026
pulisher
Mar 03, 2026

Neuronetics to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call - Yahoo Finance

Mar 03, 2026
pulisher
Mar 02, 2026

Neuronetics Amends Registration Rights, Aligns With Major Shareholder - TipRanks

Mar 02, 2026
pulisher
Mar 02, 2026

Neuronetics (STIM) revises Madryn registration rights and adds 2026 voting pact - Stock Titan

Mar 02, 2026
pulisher
Mar 01, 2026

Aug Catalysts: Why is Neuronetics Inc stock going upDollar Strength & Real-Time Sentiment Analysis - baoquankhu1.vn

Mar 01, 2026
pulisher
Feb 28, 2026

STIM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 28, 2026
pulisher
Feb 27, 2026

Neuronetics (NASDAQ:STIM) CEO Keith Sullivan Sells 8,452 Shares - MarketBeat

Feb 27, 2026
pulisher
Feb 27, 2026

Macan, Neuronetics EVP, CLO and CS, sells $4.6k in STIM stock - Investing.com

Feb 27, 2026
pulisher
Feb 27, 2026

Neuronetics (STIM) EVP sells 3,427 shares in tax withholding trade - Stock Titan

Feb 27, 2026
pulisher
Feb 27, 2026

Neuronetics (STIM) CEO sells 8,452 shares to cover RSU tax - Stock Titan

Feb 27, 2026
pulisher
Feb 26, 2026

Keith Sullivan sells shares; STIM Form 144 lists 8,452 shares (STIM) - Stock Titan

Feb 26, 2026
pulisher
Feb 26, 2026

STIM (NASDAQ: STIM) files Form 144 to sell 3,427 vested common shares - Stock Titan

Feb 26, 2026
pulisher
Feb 26, 2026

Neuronetics, Inc. (STIM) Stock Analysis: A Compelling 385% Upside Potential Awaits Investors - DirectorsTalk Interviews

Feb 26, 2026
pulisher
Feb 25, 2026

STIM Stock Earnings: Neuronetics Beats EPS, Beats Revenue for Q1 2024 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Neuronetics Grants 2025 Performance-Based Bonuses to Executives - TipRanks

Feb 25, 2026
pulisher
Feb 25, 2026

Neuronetics board approves annual cash incentive awards for top executives - Investing.com Nigeria

Feb 25, 2026
pulisher
Feb 25, 2026

Neuronetics board approves annual cash incentive awards for top executives By Investing.com - Investing.com Australia

Feb 25, 2026
pulisher
Feb 25, 2026

Neuronetics (STIM) approves 2026 annual cash incentives for CEO and top executives - Stock Titan

Feb 25, 2026
pulisher
Feb 25, 2026

Neuronetics (NASDAQ: STIM) grants 250,000 RSUs to its CFO - Stock Titan

Feb 25, 2026
pulisher
Feb 24, 2026

Peering Into Neuronetics Inc's Recent Short Interest - Benzinga

Feb 24, 2026
pulisher
Feb 24, 2026

Neuronetics (STIM) to Release Earnings on Tuesday - MarketBeat

Feb 24, 2026
pulisher
Feb 19, 2026

Neuronetics CEO Sullivan sells $55,847 in shares By Investing.com - Investing.com Australia

Feb 19, 2026
pulisher
Feb 19, 2026

Neuronetics, Inc. (NASDAQ:STIM) Short Interest Update - Defense World

Feb 19, 2026
pulisher
Feb 18, 2026

Neuronetics CEO Sullivan sells $55,847 in shares - Investing.com UK

Feb 18, 2026
pulisher
Feb 18, 2026

Neuronetics (NASDAQ:STIM) CEO Keith Sullivan Sells 33,847 Shares of Stock - MarketBeat

Feb 18, 2026
pulisher
Feb 16, 2026

Malvern-Based Neuronetics Reports Preliminary 2025 Revenue Growth and Positive Cash Flow - MyChesCo

Feb 16, 2026
pulisher
Feb 16, 2026

Neuronetics Revises Financial Results for Q4 and Full Year 2024 - MSN

Feb 16, 2026
pulisher
Feb 14, 2026

Neuronetics (STIM) Reports Q3 Loss, Misses Revenue Estimates - MSN

Feb 14, 2026
pulisher
Feb 14, 2026

What’s the RSI of Neuronetics Inc. stockShare Buyback & Real-Time Volume Surge Alerts - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

Neuronetics (STIM) Is Down 9.0% After Turning Cash-Flow Positive On NeuroStar Demand Has The Bull Case Changed? - Sahm

Feb 14, 2026
pulisher
Feb 13, 2026

Assessing Neuronetics (STIM) Valuation After Positive Cash Flow And Strong Preliminary Q4 Revenue - Yahoo Finance

Feb 13, 2026
pulisher
Feb 13, 2026

How cyclical is Neuronetics Inc.’s revenue streamJuly 2025 Decliners & AI Driven Price Forecasts - mfd.ru

Feb 13, 2026
pulisher
Feb 13, 2026

Can Neuronetics Inc. outperform in the next rallyMarket Activity Recap & Safe Entry Trade Signal Reports - mfd.ru

Feb 13, 2026
pulisher
Feb 12, 2026

Keith Sullivan Sells 40,976 Shares of Neuronetics (NASDAQ:STIM) Stock - MarketBeat

Feb 12, 2026
pulisher
Feb 12, 2026

STIM (NASDAQ: STIM) holder Keith Sullivan plans 33,847-share sale - Stock Titan

Feb 12, 2026
pulisher
Feb 11, 2026

Neuronetics Beats Expectations with Strong Q4 Revenue and Cash Flow - timothysykes.com

Feb 11, 2026
pulisher
Feb 11, 2026

Neuronetics Expects Q4 Revenue To Increase 86%; Stock Up - Nasdaq

Feb 11, 2026
pulisher
Feb 11, 2026

Neuronetics reports 86% revenue growth in Q4 2025 By Investing.com - Investing.com Canada

Feb 11, 2026
pulisher
Feb 11, 2026

Neuronetics Announces Selected Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results - The Manila Times

Feb 11, 2026
pulisher
Feb 11, 2026

Neuronetics (STIM) Stock Rises 41% After Hours: What's Going On? - Benzinga

Feb 11, 2026
pulisher
Feb 10, 2026

STIM Closes 2025 with Strong Cash Position of $34.1 Million - GuruFocus

Feb 10, 2026
pulisher
Feb 10, 2026

Neuronetics (STIM) Reports Positive Cash Flow Amid Strong Demand - GuruFocus

Feb 10, 2026
pulisher
Feb 10, 2026

Neuronetics Reports Preliminary Fiscal Q4, 2025 Results - marketscreener.com

Feb 10, 2026
pulisher
Feb 10, 2026

Neuronetics reports 86% revenue growth in Q4 2025 - Investing.com

Feb 10, 2026
pulisher
Feb 10, 2026

Neuronetics, Inc. Reports Strong Preliminary Financial Results for Fourth Quarter and Full Year 2025, Highlighting Significant Revenue Growth - Quiver Quantitative

Feb 10, 2026
pulisher
Feb 10, 2026

Neuronetics lifts 2025 revenue 99%, books positive Q4 operating cash flow - Stock Titan

Feb 10, 2026

Neuronetics Inc Azioni (STIM) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
medical_devices ZBH
$93.73
price up icon 2.21%
medical_devices STE
$221.55
price down icon 0.24%
$66.31
price down icon 2.18%
medical_devices PHG
$28.81
price down icon 0.48%
$72.65
price down icon 0.11%
medical_devices EW
$85.09
price down icon 0.80%
Capitalizzazione:     |  Volume (24 ore):